Ads
related to: multiple myeloma versus normal spep results- Transform Myeloma
Multiple Myeloma Information
and Resources for HCPs
- Frontline MM Landscape
Evolving 1st-Line MM Care
Towards Improved Outcomes
- Recent Myeloma Research
Explore Recent Findings
in Myeloma Research
- Importance of MRD-
The Importance of Achieving MRD
Negativity for Impacting Outcomes
- Transform Myeloma
freshdiscover.com has been visited by 100K+ users in the past month
discoverpanel.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
It is normal in infants. It is found in patients with X-linked agammaglobulinemia. IgA deficiency occurs in 1:500 of the population, as is suggested by a pallor in the gamma zone. Of note, hypogammaglobulinema may be seen in the context of MGUS or multiple myeloma. [citation needed]
Serum protein electrophoresis showing a paraprotein (spike/peak in the gamma zone) in a patient with multiple myeloma.. A myeloma protein is an abnormal antibody (immunoglobulin) or (more often) a fragment thereof, such as an immunoglobulin light chain, that is produced in excess by an abnormal monoclonal proliferation of plasma cells, typically in multiple myeloma or Monoclonal gammopathy of ...
Monoclonal gammopathy, also known as paraproteinemia, is the presence of excessive amounts of myeloma protein or monoclonal gamma globulin in the blood. It is usually due to an underlying immunoproliferative disorder or hematologic neoplasms, especially multiple myeloma. It is sometimes considered equivalent to plasma cell dyscrasia.
Monoclonal gammopathy of undetermined significance (MGUS) is a plasma cell dyscrasia in which plasma cells or other types of antibody-producing cells secrete a myeloma protein, i.e. an abnormal antibody, into the blood; this abnormal protein is usually found during standard laboratory blood or urine tests.
MGUS is a relatively stable condition afflicting 3% of people aged 50 and 5% of people aged 70; it progresses to multiple myeloma at a rate of 0.5–1% cases per year; smoldering multiple myeloma does so at a rate of 10% per year for the first 5 years, but then falls off sharply to 3% per year for the next 5 years and thereafter to 1% per year.
Light chain multiple myeloma is diagnosed in patients who have: a) the criteria for diagnosis of multiple myeloma except having a serum free light chain ratio outside the normal range of 0.26 to 1.65 without evidence of an intact immunoglobulin or free heavy chain; or b) an extreme free light chain ratio, i.e. outside the range of 0.02 to 100 ...
Increases in certain proteins that are typically present in relatively low concentrations, such as acute phase reactants and polyclonal immunoglobulins caused by inflammation, late-stage liver disease, and infections, can result in mild hyperproteinemia. Normal total protein levels are not sufficient to rule out multiple myeloma or other ...
Usually MGRS disorders have small levels of circulating M-proteins (due to the small clonal burden of the underlying B-cell or plasma cell disorder) thus decreasing the sensitivity of serum protein electrophoresis (SPEP). [1] Serum immunofixation electrophoresis is 10 times more sensitive than SPEP in the identification of M-proteins in MGRS. [1]
Ads
related to: multiple myeloma versus normal spep resultsfreshdiscover.com has been visited by 100K+ users in the past month
discoverpanel.com has been visited by 10K+ users in the past month